Hepatocellular Carcinoma: Molecular Diagnosis and Perspectives for Therapy.
作者信息
Premkumar Madhumita, Chawla Yogesh
机构信息
Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India.
Department of Hepatology, Kalinga Institute of Medical Sciences, Bhubaneshwar, Odisha, India.
出版信息
J Clin Exp Hepatol. 2024 Nov-Dec;14(6):102413. doi: 10.1016/j.jceh.2024.102413. Epub 2024 Sep 21.
Abstract
摘要
相似文献
1
Hepatocellular Carcinoma: Molecular Diagnosis and Perspectives for Therapy.肝细胞癌：分子诊断与治疗前景
J Clin Exp Hepatol. 2024 Nov-Dec;14(6):102413. doi: 10.1016/j.jceh.2024.102413. Epub 2024 Sep 21.
2
Contrast-enhanced ultrasound for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.对比增强超声在慢性肝病成人肝细胞癌诊断中的应用。
Cochrane Database Syst Rev. 2022 Sep 2;9(9):CD013483. doi: 10.1002/14651858.CD013483.pub2.
3
Computed tomography for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.计算机断层扫描在慢性肝病成人肝细胞癌诊断中的应用。
Cochrane Database Syst Rev. 2021 Oct 6;10(10):CD013362. doi: 10.1002/14651858.CD013362.pub2.
4
Magnetic resonance imaging for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.磁共振成像在慢性肝病成人肝细胞癌诊断中的应用。
Cochrane Database Syst Rev. 2022 May 6;5(5):CD014798. doi: 10.1002/14651858.CD014798.pub2.
5
The combination of transcatheter arterial chemoembolisation (TACE) and thermal ablation versus TACE alone for hepatocellular carcinoma.经导管动脉化疗栓塞术（TACE）联合热消融与单纯 TACE 治疗肝细胞癌的疗效比较。
Cochrane Database Syst Rev. 2022 Jan 4;1(1):CD013345. doi: 10.1002/14651858.CD013345.pub2.
6
Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis.丙型肝炎患者中检测肝细胞癌的甲胎蛋白检测特征。一项系统评价与批判性分析。
Ann Intern Med. 2003 Jul 1;139(1):46-50. doi: 10.7326/0003-4819-139-1-200307010-00012.
7
Alpha-foetoprotein and/or liver ultrasonography for screening of hepatocellular carcinoma in patients with chronic hepatitis B.甲胎蛋白和/或肝脏超声检查用于慢性乙型肝炎患者肝细胞癌的筛查。
Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD002799. doi: 10.1002/14651858.CD002799.pub2.
8
Ablative and non-surgical therapies for early and very early hepatocellular carcinoma: a systematic review and network meta-analysis.早期和极早期肝细胞癌的消融和非手术治疗：系统评价和网络荟萃分析。
Health Technol Assess. 2023 Dec;27(29):1-172. doi: 10.3310/GK5221.
9
External beam radiotherapy for unresectable hepatocellular carcinoma.不可切除肝细胞癌的外照射放疗
Cochrane Database Syst Rev. 2017 Mar 7;3(3):CD011314. doi: 10.1002/14651858.CD011314.pub2.
10
Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.早期或极早期肝细胞癌患者的管理：一项网络荟萃分析尝试
Cochrane Database Syst Rev. 2017 Mar 28;3(3):CD011650. doi: 10.1002/14651858.CD011650.pub2.
本文引用的文献
1
Machine-Learning-Based Identification of Key Feature RNA-Signature Linked to Diagnosis of Hepatocellular Carcinoma.基于机器学习的与肝细胞癌诊断相关的关键特征RNA标志物识别
J Clin Exp Hepatol. 2024 Nov-Dec;14(6):101456. doi: 10.1016/j.jceh.2024.101456. Epub 2024 Jun 14.
2
Investigating the Influence of Preoperative Trans Arterial Embolization (TAE) and Predictive Potential of Circulating Tumor Cells (CTCs) in Prognosis of Hepatocellular Carcinoma.探讨术前经动脉栓塞术（TAE）对肝细胞癌预后的影响及循环肿瘤细胞（CTC）的预测潜力。
J Clin Exp Hepatol. 2024 Nov-Dec;14(6):101445. doi: 10.1016/j.jceh.2024.101445. Epub 2024 May 18.
3
Systemic Therapies for Hepatocellular Carcinoma in India.印度肝细胞癌的全身治疗
J Clin Exp Hepatol. 2024 Nov-Dec;14(6):101440. doi: 10.1016/j.jceh.2024.101440. Epub 2024 May 6.
4
Comparative Immunohistochemical Analysis of Clinicopathological Subgroups in Hepatocellular Carcinomas from Japan and Indonesia.日本和印度尼西亚肝细胞癌临床病理亚组的比较免疫组织化学分析
J Clin Exp Hepatol. 2024 Nov-Dec;14(6):101451. doi: 10.1016/j.jceh.2024.101451. Epub 2024 May 23.
5
2023 Update of Indian National Association for Study of the Liver Consensus on Management of Intermediate and Advanced Hepatocellular Carcinoma: The Puri III Recommendations.印度国家肝脏研究协会关于中晚期肝细胞癌管理共识的2023年更新：普里III建议
J Clin Exp Hepatol. 2024 Jan-Feb;14(1):101269. doi: 10.1016/j.jceh.2023.08.005. Epub 2023 Aug 19.
6
Safety and Efficacy of Atezolizumab-Bevacizumab in Real World: The First Indian Experience.阿替利珠单抗联合贝伐单抗在真实世界中的安全性和有效性：印度的首次经验
J Clin Exp Hepatol. 2023 Jul-Aug;13(4):618-623. doi: 10.1016/j.jceh.2023.02.003. Epub 2023 Feb 10.
7
Multi-center prospective survey of hepatocellular carcinoma in Kerala: More than 1,200 cases.喀拉拉邦肝细胞癌的多中心前瞻性调查：超过 1200 例。
Indian J Gastroenterol. 2023 Apr;42(2):233-240. doi: 10.1007/s12664-022-01314-8. Epub 2023 May 8.
8
Machine Learning Predictive Model to Guide Treatment Allocation for Recurrent Hepatocellular Carcinoma After Surgery.机器学习预测模型指导手术治疗后复发性肝细胞癌的治疗分配。
JAMA Surg. 2023 Feb 1;158(2):192-202. doi: 10.1001/jamasurg.2022.6697.
9
Hepatocellular carcinoma.肝细胞癌。
Nat Rev Dis Primers. 2021 Jan 21;7(1):6. doi: 10.1038/s41572-020-00240-3.
10
Changing role of histopathology in the diagnosis and management of hepatocellular carcinoma.组织病理学在肝细胞癌诊断和治疗中的角色转变。
World J Gastroenterol. 2018 Sep 21;24(35):4000-4013. doi: 10.3748/wjg.v24.i35.4000.
Zotero 插件